Product category:
Nucleic acid sequencing and synthesis
News Release from: Metasense Technologies | Subject: DNA analogues
Edited by the Laboratorytalk Editorial
Team on 28 July 2003
Advances in basic technology for gene
silencing
These novel DNA modifications are said to be the first in 20 years to demonstrate all of the desired properties for antisense gene silencing using DNA fragments
MetaSense Technologies has announced the publication of the first biochemical, biophysical, and biological studies on a set of two new DNA analogues in the journal Nucleic Acid Research (31 (14), 4109-4118, 2003) These novel DNA modifications, phosphonocarboxylates, are said to be the first in 20 years to demonstrate all of the desired properties for antisense gene silencing using DNA fragments
This article was originally published on Laboratorytalk on 5 Feb 2003 at 8.00am (UK)
Related stories
The wait for new DNA analogues is over
First novel phosphonocarboxylate DNA modifications in 20 years demonstrate all of the chemical and biochemical properties desired for DNA therapeutics
Haematology analyser fills gap in range
With a throughput of 80 samples per hour, this will suit laboratories with workloads of up to 350 samples per day and fills the gap between 60 and 120 sample per hour machines
Since the introduction of antisense technology almost two decades ago, few if any DNA analogues have shown such a remarkable combination of desirable properties.
Biochemically, these new DNA analogues were shown to hybridise to complementary RNA molecules in a sequence specific manner, were highly nuclease resistant, and RNase H active.
Specific constructs of these analogues were shown to have greatly enhanced rates of RNase H cleavage, even over the natural DNA/RNA substrates.
Further reading
Innovative new products emphasise R and D
Completely new bench-top analyser combines the latest technological advances and a large test menu with a faster throughput
Getting the right haematology mix, automatically
Latest development to haematology analyser range incorporates a cutting edge fully integrated data management system that enables onboard validation of results
Biophysically, these DNA analogues when hybridised to complementary RNA gave structures highly analogous to natural DNA/RNA duplexes.
Biologically, specific constructs were shown to readily penetrate cell membranes.
The publication was submitted by the laboratory of Distinguished Professor Marvin H Caruthers from the University of Colorado, Department of Chemistry and Biochemistry.
"The data generated to date on these analogues has been truly remarkable; so is the interest that they are generating in the research community.
"Our goal is still to get these new tools into the hands of researchers quickly, we have great confidence in what will result" said Dirk Dellinger, president of MetaSense Technologies, the corporation exclusively licensed to sell reagents to make oligo.
"Today, the field of gene silencing is becoming a very exciting and revolutionary place.
"Whatever technique is used (antisense or RNAi) an intact (stabilised), active molecule is required to penetrate the cell; from the recent data generated we believe that phosphonocarboxylates will play a significant role in the future of these technologies." he concluded.
"We never expected such astonishing data to be generated so quickly.
"The key appears to be in developing good phosphorus chemistry that resulted in desired properties and behaviors," stated Professor James G Lindberg, chief technology officer for MetaSense Technologies.
"I believe that the ability to quantitatively couple phosphonocarboxylates to any biological molecule has even broader implications beyond gene silencing (antisense, RNAi, or gene therapy), and into phosphopeptides or small molecule therapeutics.
"Although I can't predict the future, I can't wait to see the results of further investigations," he remarked.
• Metasense Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
